TSAAI 2025 Annual Meeting
The Tennessee Society of Allergy, Asthma and Immunology (TSAAI) was established to coordinate the efforts of specialists in allergy, asthma and immunology in the state of Tennessee, principally for scientific and education purposes and to promote the highest standards of practitioners in the fields of allergy, asthma and immunology.
TSAAI's annual educational meeting consists of presentations by recognized speakers in the field of allergy, asthma and immunology.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology and the Tenessee Society of Allergy, Asthma & Immunology (TSAAI). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 8 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
No commercial support was received for this activity.
Target Audience
Practicing allergists
Allied health professionals
Learning Objectives
At the conclusion of this Activity learners should be able to…
1. Diagnose conditions of upper airway problems associated with asthma or conditions with symptoms similar to asthma.
2. Assess asthma co-morbidities and modify treatment goals for asthma.
3. Attendees will learn how to utilize A/I and gain the skills necessary to better manage the medical challenges they face in clinic and learn how to more efficiently run a medical practice using A/I.
4. Recognize laryngeal disorders contributing to asthma symptoms
5. Identify how to diagnose hyper-IgE disorders, conditions related to eosinophilia, allergy and anaphylaxis.
6. Discuss novel treatment strategies for HAE and anaphylaxis.
7. Identify patients with secondary hypogammaglobulinemia that will benefit from immunoglobulin replacement.
TSAAI 2025 Annual Meeting
Dollywood’s HeartSong Conference Center, Pigeon Forge, TN
July 18-20, 2025
Friday, July 18, 2025
4:00 – 5:00 pm Attendee Early Check-In (Optional) - Conference Center Hallway
Saturday, July 19, 2025
All CME Sessions will be held in Salon C/D
7:15 – 7:45 am Attendee Check-In
7:15 – 7:45 am Breakfast & exhibits (Salon A/B)
7:45 – 8:00 am Introduction, Ty Prince, MD
8:00 – 9:00 am AI in Allergy, Chris Chang, MD
Q & A
9:00 – 10:00 am Hereditary Angioedema, Marc Riedl, MD
Q & A
10:00 – 10:30 am Break & exhibits (Salon A/B)
10:30 – 11:30 am The Sights and Sounds of Asthma, Nina Ramirez, MD
Q & A
11:30 – 12:30 pm Alternate Paths to Immunodeficiency: Secondary and Beyond, Yasmin Khan, MD
Q & A
Sunday, July 20, 2025
All CME Sessions will be held in Salon C/D
7:15 – 7:45 am Breakfast & exhibits (Salon A/B)
8:00 – 9:00 am GERD, Laryngeal Disorders and Vocal Cord Dysfunction, Dennis Ledford, MD
Q & A
9:00 – 10:00 am Anaphylaxis, Jay Lieberman, MD
Q & A
10:00 – 10:30 am Break & exhibits (Salon A/B)
10:30 – 11:30 am Bronchiectasis, Allergic Bronchopulmonary Aspergillosis, Cystic Fibrosis, Sleep Apnea and Others, Dennis Ledford, MD
Q & A
11:30 – 12:30 pm Hyper IgE, Hypereosinophilia - When to Worry About More Than Allergy, Kelli Williams, MD
Q & A
12:30 pm Meeting adjourn
All relevant financial relationships with ineligible companies have been mitigated.
Christopher Chang, MD, Speaker
Speaker: ADMA
Nicholas Kolinsky, DO, Program Chair and Planner
Advisor: AstraZeneca, Pharming, Hikma, ADMA Biologics, KalVista, Blueprint Medicines
Speaker: AstraZeneca, Amgen, Hikma, GlaxoSmithKline, CSL Behring, Sanofi, Regeneron, Grifols
Dennis Ledford, MD, Speaker
Consultant: Amgen
Jay Lieberman, MD, Speaker
Advisor: ARS, Aquestive, Theravia, Genentech, Kaleo
Consultant: ARS, Theravia, Amgen, Abbvie, Celldex, Genentech, Kaleo
Researcher: DBV
Tidence Prince, MD, Program Chair and Planner
Speaker: AstraZeneca, GSK, Takeda
Nina Ramirez, MD, Speaker
Advisor: AstraZeneca, Sanofi Regeneron, Amgen
Speaker: AstraZeneca, Sanofi Regeneron
Marc Riedl, MD MS, Speaker
Consultant: Astria, Biocryst, Biomarin, Celldex, CSL Behring, Cycle Pharmacy, Grifols, Intellia, Ionis, Kalvista, Novartis, Pharming, Pharvaris, Sanofi-Regeneron, Takeda
Researcher: Astria, Biocryst, Biomarin, CSL Behring, Ionis, Intellia, Kalvista, Pharvaris, Takeda
Speaker: Biocryst, CSL Behring, Grifols, Pharming, Takeda
Kelli Williams, MD, Speaker
Advisor: Pharming Healthcare, Amgen Inc.
Consultant: ADMA Biologics, Pharming Healthcare, Amgen Inc.
Researcher: AstraZeneca, GSK, Cogent Biosciences, ADMA Biologics, Amgen Inc.
Speaker: Pharming Healthcare
The following have no relevant financial relationships with ineligible companies to disclose:
Yasmin Khan, MD, Speaker
Karthik Krishnan, MD, Program Chair and Planner
Michelle Kittle, Meeting Coordinator
Chloe Miller, Meeting Coordinator
Available Credit
- 8.00 AMA PRA Category 1 Credit™
- 8.00 Attendance

Facebook
X
LinkedIn
Forward